Zika Virus Disease
Prevention & Cure
Seiten
2017
Nova Science Publishers Inc (Verlag)
978-1-5361-0769-2 (ISBN)
Nova Science Publishers Inc (Verlag)
978-1-5361-0769-2 (ISBN)
The author was motivated to write this important book because currently there is no systematically-written document on the ZIKV disease, which could serve at this crucial moment as a textbook for medical students, physicians, nurses, and other healthcare providers as well as a reference book for basic researchers, professors, and the general public. The original concept of ZIKV-Charnolopathy due to compromised mitochondrial bioenergetics in highly vulnerable (neural progenitor cells, spermatocytes, oocytes etc.) cells and its amelioration by physiological and/or pharmacological interventions is based on years of research experience. This book describes unique organ and disease-specific Charnoly body (CB) inhibitors, charnolophagy inducers, CB sequestration inhibitors, and chanolophagosome stabilisers as promising charnolopharmacotherapeutics. They are meant to aid in the prevention and treatment of the ZIKV-linked diversified spectrum of neurodevelopmental anomalies (embryopathies) in newborn infants and Guillain Barre Syndrome (GBS) in adults. Clinical management of ZIKV-induced GBS employing IV immunoglobulin and plasmapheresis (plasma exchange) is also described.
Sushil Sharma (Saint James School of Medicine, St. Vincent, St Vincent and the Grenadines)
For Complete Table of Contents, please visit our website at: https://www.novapublishers.com/catalog/product_info.php?products_id=60749
Erscheinungsdatum | 02.02.2017 |
---|---|
Verlagsort | New York |
Sprache | englisch |
Maße | 180 x 260 mm |
Gewicht | 1102 g |
Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Gastroenterologie |
ISBN-10 | 1-5361-0769-7 / 1536107697 |
ISBN-13 | 978-1-5361-0769-2 / 9781536107692 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Buch | Softcover (2024)
Urban & Fischer in Elsevier (Verlag)
CHF 76,00